Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection.

AIM: To examine the effect of interleukin-1-beta (IL-1β) promoter region C-511T and IL-1 receptor antagonist (IL-1RN) polymorphism among the patients with chronic hepatitis B virus (HBV) infection (HCC and non-HCC). METHODS: Genomic DNA from 136 Thai patients with chronic HBV infection (HCC = 46 and non-HCC = 90) and 152 healthy individuals was genotyped for IL-1β gene polymorphism (-511) using polymerase chain reaction with sequence specific primers (PCR-SSP). The variable number of tandem repeats (VNTR) of IL-1RN gene was assessed by a PCR-based assay. The association between these genes and status of the disease was evaluated by χ2 test. RESULTS: IL-1B-511 genotype C/C was found to be significantly different in patients with HCC when compared with healthy individuals (P  = 0.036, OR = 2.29, 95%CI = 1.05-4.97) and patients without HCC (P =0.036, OR = 2.52, 95%CI=1.05-6.04). Analysis of allele frequencies of IL-1B-511 showed that IL-1B-511 C allele was also significantly increased in patients with HCC, compared to that in healthy control (P  = 0.033, OR = 1.72, 95%CI=1.04-2.84). However, no significant association in IL-1RN gene was found between the two groups. CONCLUSION: IL-1B-511C allele, which may be associated with high IL-1B production in the liver, is a genetic marker for the development of HCC in chronic hepatitis B patients in Thai population.

[1]  A. Kato,et al.  Nonsteroidal anti-inflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production. , 1998, Biochemical and biophysical research communications.

[2]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[3]  Schneider,et al.  A tumour necrosis factor‐alpha (TNF‐α) promoter polymorphism is associated with chronic hepatitis B infection , 1998 .

[4]  G. Duff,et al.  A Physical Map of the Region Encompassing the Human Interleukin-1α, Interleukin-1β, and Interleukin-1 Receptor Antagonist Genes , 1994 .

[5]  Pingan Zhang,et al.  Polymorphisms of interleukin-1B and interleukin-1 receptor antagonist genes in patients with chronic hepatitis B. , 2004, World journal of gastroenterology.

[6]  J. van Hattum,et al.  HLA antigens in patients with various courses after hepatitis B virus infection , 1987, Hepatology.

[7]  A. Zuckerman,et al.  Protective efficacy of hepatitis B vaccines in neonates , 1994, Journal of medical virology.

[8]  Santtila,et al.  Presence of the IL‐1RA Allele 2 (IL1RN*2) is Associated with Enhanced IL‐1β Production In Vitro , 1998, Scandinavian journal of immunology.

[9]  Jian-Min Yuan,et al.  Effect of cytokine genotypes on the hepatitis B virus‐hepatocellular carcinoma association , 2005, Cancer.

[10]  W. M. Lee,et al.  Hepatitis B virus infection. , 1997, The New England journal of medicine.

[11]  J. Jackson,et al.  Manipulation of Distinct NFκB Proteins Alters Interleukin-1β-induced Human Rheumatoid Synovial Fibroblast Prostaglandin E2 Formation* , 1996, The Journal of Biological Chemistry.

[12]  C. Ki,et al.  Novel interleukin 1β polymorphism increased the risk of gastric cancer in a Korean population , 2004, Journal of Gastroenterology.

[13]  M. Onda,et al.  Association of the interleukin-1 β genetic polymorphism and gastric cancer risk in Japanese , 2001, Journal of Gastroenterology.

[14]  P. Pharoah,et al.  Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. , 2001, Gastroenterology.

[15]  K. Welsh,et al.  Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. , 2002, American journal of respiratory and critical care medicine.

[16]  S. Dong,et al.  Interleukin‐1B (IL‐1B) polymorphisms and gastric mucosal levels of IL‐1β cytokine in Korean patients with gastric cancer , 2005, International journal of cancer.

[17]  J. Batchelor,et al.  HLA and hepatitis B infection , 1994, The Lancet.

[18]  Y. Shiratori,et al.  Interleukin‐1β gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection , 2003 .

[19]  Leif E. Peterson,et al.  Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1β production in Helicobacter pylori infection , 2002 .

[20]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[21]  D. Dhar,et al.  Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  Hongbing Shen,et al.  Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. , 2004, Cancer letters.

[23]  T. Tajiri,et al.  Molecular therapy: clinical applications. intra-arterial adenoviruses administration. , 2003, Journal of experimental & clinical cancer research : CR.

[24]  K. Matsuo,et al.  Interleukin 1 Polymorphisms, Lifestyle Factors, and Helicobacter pylori Infection , 2001, Japanese journal of cancer research : Gann.

[25]  L. Crofford,et al.  Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin‐1: a potential mechanism for inflammatory angiogenesis , 1995, FEBS letters.

[26]  P. Laippala,et al.  A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 beta plasma levels in healthy individuals. , 2000, European cytokine network.

[27]  M. M. Wu,et al.  Hepatitis B virus markers in Chinese twins. , 1989, Anticancer research.

[28]  Jung-Hwan Yoon,et al.  Association of TNF-α promoter polymorphisms with the clearance of hepatitis B virus infection , 2003 .

[29]  C. Caldas,et al.  Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. , 2002, Journal of the National Cancer Institute.

[30]  R. Perrillo.  How will we use the new antiviral agents for hepatitis B? , 2002, Current gastroenterology reports.

[31]  M. Carrington,et al.  correction: The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer , 2001, Nature.

[32]  M. Barnardo,et al.  Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). , 1995, Tissue antigens.

[33]  E. El-Omar,et al.  Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. , 2002, Gastroenterology.

[34]  Z. Tian,et al.  IL-1β Attenuates IFN-αβ-Induced Antiviral Activity and STAT1 Activation in the Liver: Involvement of Proteasome-Dependent Pathway1 , 2000, The Journal of Immunology.

[35]  A. E. Yeo,et al.  Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan. , 2003, The Journal of infectious diseases.

[36]  M. Carrington,et al.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.

[37]  S. Ahn,et al.  Association between hepatitis B virus infection and HLA‐DR type in Korea , 2000, Hepatology.

[38]  C. Caldas,et al.  A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. , 2003, Gastroenterology.

[39]  Tirza Klein,et al.  Cytokine Gene Polymorphisms in Patients Infected With Hepatitis B Virus , 2003, American Journal of Gastroenterology.

[40]  L. Giacomelli,et al.  Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.